FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999295388> ?p ?o ?g. }

• W1999295388 endingPage "144" @default.
• W1999295388 startingPage "138" @default.
• W1999295388 abstract "<i>Aim:</i> To compare the effects of intravitreal bevacizumab on different morphologic patterns of diabetic macular edema (DME) classified using optical coherence tomography (OCT). <i>Materials and Methods:</i> Medical records for 65 eyes of 48 patients were retrospectively reviewed, and each subject was classified as one of three DME types according to the OCT features: diffuse retinal thickening (DRT), cystoid macular edema (CME), serous retinal detachment (SRD). Subjects were given three monthly intravitreal injections of bevacizumab (1.25 mg/0.05 ml). The clinical course of best-corrected visual acuity (BCVA) with a logarithm of the minimum angle of resolution chart and central foveal thickness (CFT) using OCT was monitored for 12 months after the injections. On follow-up, injections were repeated if DME remained or was aggravated. <i>Results:</i> Of the 65 eyes with DME, 29 eyes were of the DRT type, 21 of the CME type, and 15 of the SRD type. Before the injection, CFT and BCVA were, respectively, 377.1 ± 145.9 µm and 0.54 ± 0.36 in the DRT type, 427.7 ± 143.1 µm and 0.59 ± 0.42 in the CME type, and 485.1 ± 187.1 µm and 0.65 ± 0.27 in the SRD type; there was no significant difference in CFT and BCVA between DME types (p > 0.05). At 6 months, the changes in BCVA and CFT differed significantly between OCT types (p < 0.05). At 12 months, changes in CFT and BCVA from baseline were not significantly different between groups (p > 0.05). The DRT type was associated with a greater reduction in the CFT and greater BCVA improvement than the CME or SRD types. <i>Conclusions:</i> Three monthly injections of intravitreal bevacizumab seem to be effective treatment in the first 6 months, but the therapeutic effect is temporary and repeated injections of bevacizumab should be considered to maintain the therapeutic effect after 6 months. In addition, intravitreal injection of bevacizumab was more effective in the DRT type than in the CME or SRD types of DME." @default.
• W1999295388 created "2016-06-24" @default.
• W1999295388 creator A5008246684 @default.
• W1999295388 creator A5027235256 @default.
• W1999295388 creator A5031673430 @default.
• W1999295388 creator A5034802181 @default.
• W1999295388 creator A5080995843 @default.
• W1999295388 date "2011-01-01" @default.
• W1999295388 modified "2023-10-18" @default.
• W1999295388 title "Effect of Intravitreal Bevacizumab Based on Optical Coherence Tomography Patterns of Diabetic Macular Edema" @default.
• W1999295388 cites W1482143222 @default.
• W1999295388 cites W1485105115 @default.
• W1999295388 cites W1489720007 @default.
• W1999295388 cites W1964233473 @default.
• W1999295388 cites W1977181510 @default.
• W1999295388 cites W1977776099 @default.
• W1999295388 cites W1988410572 @default.
• W1999295388 cites W1998848395 @default.
• W1999295388 cites W1999354155 @default.
• W1999295388 cites W2011046688 @default.
• W1999295388 cites W2012414883 @default.
• W1999295388 cites W2022886290 @default.
• W1999295388 cites W2036712095 @default.
• W1999295388 cites W2052023322 @default.
• W1999295388 cites W2059911025 @default.
• W1999295388 cites W2062681592 @default.
• W1999295388 cites W2069618306 @default.
• W1999295388 cites W2072111558 @default.
• W1999295388 cites W2077244914 @default.
• W1999295388 cites W2077389784 @default.
• W1999295388 cites W2083092631 @default.
• W1999295388 cites W2097612780 @default.
• W1999295388 cites W2101039050 @default.
• W1999295388 cites W2102719227 @default.
• W1999295388 cites W2118965640 @default.
• W1999295388 cites W2140826298 @default.
• W1999295388 cites W2151129590 @default.
• W1999295388 cites W2162960868 @default.
• W1999295388 cites W2546961712 @default.
• W1999295388 cites W272611611 @default.
• W1999295388 doi "https://doi.org/10.1159/000330045" @default.
• W1999295388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21822008" @default.
• W1999295388 hasPublicationYear "2011" @default.
• W1999295388 type Work @default.
• W1999295388 sameAs 1999295388 @default.
• W1999295388 citedByCount "69" @default.
• W1999295388 countsByYear W19992953882013 @default.
• W1999295388 countsByYear W19992953882014 @default.
• W1999295388 countsByYear W19992953882015 @default.
• W1999295388 countsByYear W19992953882016 @default.
• W1999295388 countsByYear W19992953882017 @default.
• W1999295388 countsByYear W19992953882018 @default.
• W1999295388 countsByYear W19992953882019 @default.
• W1999295388 countsByYear W19992953882020 @default.
• W1999295388 countsByYear W19992953882021 @default.
• W1999295388 countsByYear W19992953882022 @default.
• W1999295388 countsByYear W19992953882023 @default.
• W1999295388 crossrefType "journal-article" @default.
• W1999295388 hasAuthorship W1999295388A5008246684 @default.
• W1999295388 hasAuthorship W1999295388A5027235256 @default.
• W1999295388 hasAuthorship W1999295388A5031673430 @default.
• W1999295388 hasAuthorship W1999295388A5034802181 @default.
• W1999295388 hasAuthorship W1999295388A5080995843 @default.
• W1999295388 hasConcept C118487528 @default.
• W1999295388 hasConcept C134018914 @default.
• W1999295388 hasConcept C141071460 @default.
• W1999295388 hasConcept C2776694085 @default.
• W1999295388 hasConcept C2777802072 @default.
• W1999295388 hasConcept C2778257484 @default.
• W1999295388 hasConcept C2778818243 @default.
• W1999295388 hasConcept C2779829184 @default.
• W1999295388 hasConcept C2780347916 @default.
• W1999295388 hasConcept C2780827179 @default.
• W1999295388 hasConcept C2985127711 @default.
• W1999295388 hasConcept C555293320 @default.
• W1999295388 hasConcept C71924100 @default.
• W1999295388 hasConceptScore W1999295388C118487528 @default.
• W1999295388 hasConceptScore W1999295388C134018914 @default.
• W1999295388 hasConceptScore W1999295388C141071460 @default.
• W1999295388 hasConceptScore W1999295388C2776694085 @default.
• W1999295388 hasConceptScore W1999295388C2777802072 @default.
• W1999295388 hasConceptScore W1999295388C2778257484 @default.
• W1999295388 hasConceptScore W1999295388C2778818243 @default.
• W1999295388 hasConceptScore W1999295388C2779829184 @default.
• W1999295388 hasConceptScore W1999295388C2780347916 @default.
• W1999295388 hasConceptScore W1999295388C2780827179 @default.
• W1999295388 hasConceptScore W1999295388C2985127711 @default.
• W1999295388 hasConceptScore W1999295388C555293320 @default.
• W1999295388 hasConceptScore W1999295388C71924100 @default.
• W1999295388 hasIssue "3" @default.
• W1999295388 hasLocation W19992953881 @default.
• W1999295388 hasLocation W19992953882 @default.
• W1999295388 hasOpenAccess W1999295388 @default.
• W1999295388 hasPrimaryLocation W19992953881 @default.
• W1999295388 hasRelatedWork W2026686158 @default.
• W1999295388 hasRelatedWork W2087604601 @default.
• W1999295388 hasRelatedWork W2216990732 @default.
• W1999295388 hasRelatedWork W2223380039 @default.

• next